Agent Capital overview
Stories about Agent Capital
Agent Capital collects $59.55m for sophomore fund
Agent Capital has raised $59.55 million for its second fund, according to an SEC filing.
Agent Capital collects nearly $53m for sophomore fund
Agent Capital has raised nearly $53 million for its second fund, according to an SEC filing.
Verge Genomics raises $32 mln from DFJ, ALS Investment Fund, Agent Capital, others
Verge Genomics said it raised $32 million of Series A capital in a round led by DFJ and joined by new investors WuXi AppTec’s Corporate Venture Fund, ALS Investment Fund, Agent Capital, and OS Fund.
Agent Capital collects $57.75 mln for $150 mln-targeted fund
Cambridge, Massachusetts-based Agent Capital, a biotech-focused venture firm, has raised $57.75 million for its initial fund, according to an SEC filing https://www.sec.gov/Archives/edgar/data/1706036/000170603618000003/xslFormDX01/primary_doc.xml The target is $150 million.
Agent Capital raises $52 mln for maiden venture capital fund
Agent Capital has raised $52 million for a maiden venture capital fund, according to a filing with the SEC.
Agent Capital contact information
Offices
1400 Main Street, Floor 1, Waltham, 02451, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Ms. Julie Gionfriddo | Job titleHead of Investor Relations and Fundraising | LocationWaltham, United States | Email  ------- |
| Key ContactDr. Preston Noon | Job titleCo-Founder and General Partner | LocationWaltham, United States | Email -------- |
| Dr. Geeta Vemuri | Job titleFounder and Managing Partner | LocationWaltham, United States | Email --------- |
| Dr. Anthony DiNatale | Job titleVice President | LocationWaltham, United States | Email ------ |
Agent Capital funds managed
Funds in market: 1
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size ------ | Open dateFeb 2024 | Strategy --------- | |
Closed funds: 2
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size -------- | Close dateMar 2023 | Strategy -------- | |
Fund size ----- | Close dateNov 2019 | Strategy ------ | |
Stories that mention Agent Capital
Women-led venture capital firms
We have updated our exclusive directory of more than 400 women-led venture capital firms from around the world.
Bioluminescence Ventures taps Murray as senior partner
Most recently, Murray was a general partner at Agent Capital.
RNA medicines provider Orbital Therapeutics scores $270m Series A
ARCH Venture Partners led the round.
VC-backed Entrada Therapeutics raises $181.5m for IPO
Entrada Therapeutics, a biotech company, has raised $181.5 million for its IPO after pricing its over 9 million shares at $20 per share.
Immunitas Therapeutics procures $58m Series B
Immunitas Therapeutics, a single cell genomics-based therapeutics company, has secured $58 million in Series B financing.
Metagenomi grabs $65m Series A
Metagenomi, a next-generation gene editing company, has secured $65 million in Series A financing.
VC-backed Pliant Therapeutics goes public
South San Francisco-based Pliant Therapeutics Inc, a developer of therapies that treat fibrosis, has raised $144 million for its IPO after it priced its 9 million shares at $16 per share.
Palvella Therapeutics rakes in $45m Series C
Wayne, Pennsylvania-based Palvella Therapeutics Inc., a rare disease biopharmaceutical company, has raised $45 million in Series C financing.